Head to head
Cresud vs 3M
Side-by-side on the measures that matter, with a plain-English read. Full detail: CRESY · MMM
CRESY
Cresud
7.79-2.81%
1-year price shape — -27% over the period
Quant Rating E · 15/100
vs
MMM
3M
177.99-0.27%
1-year price shape — +10% over the period
Quant Rating C · 51/100
1-year performance, rebased to 100
It’s close.
| CRESY | MMM | |
|---|---|---|
| Snapshot | ||
| Sector | Conglomerates | -- |
| Last price | 7.79 | 177.99 |
| Change today | -2.81% | -0.27% |
| 1-year return | -27.3% | +9.7% |
| Market cap | $552.20M | $91.97B |
| 52-week range | 7.73 – 12.83 | 137.44 – 196.08 |
| Valuation | ||
| P/E (TTM) | 4.52 | 26.57 |
| P/E percentile, own 5-yr range | 58th | 83rd |
| P/B | 0.59 | 22.28 |
| Dividend yield | 7.87% | 1.72% |
| Profitability & growth | ||
| EPS (TTM) | 1.72 | 6.00 |
| Net profit (TTM) | $122.21M | $3.10B |
| Revenue (TTM) | $1.29T | $25.25B |
| Provider revenue period date | 2026-06-29 | 2026-09-29 |
| Revenue growth (YoY) | +8.3% | +1.0% |
| Gross margin | 39.0% | 39.5% |
| Operating margin | 17.0% | 20.1% |
| Net margin | 12.9% | 14.0% |
| Free cash flow (TTM) | $5.93B | $2.68B |
| Provider cash-flow period date | 2026-06-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 51.5% | 77.0% |
| Insider activity (12mo) | 6 buy / 6 sell | 24 buy / 22 sell |
| Short interest (% of float) | 1.1% | 1.9% |
| Analyst consensus | -- | 36% buy / 55% hold / 9% sell (11) |
| Analyst price target | -- | $198 (+11%) |
| StockVane view | ||
| StockVane Quant Rating | E (15) | C (51) |
| Company | ||
| Employees | 2,868 | 60,500 |
| Founded | 1936 | 1929 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.